MiR-99b-5p expression and response to tyrosine kinase inhibitor treatment in clear cell renal cell carcinoma patients

A number of treatments targeting VEGF or mTOR pathways have been approved for metastatic clear cell Renal Cell Carcinoma (ccRCC), but the majority of patients show disease progression after first line therapy with a very low rate of complete or long-term responders. It has been shown that miRs may p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Lukamowicz-Rajska, Magdalena, Mittmann, Christiane, Prummer, Michael, Zhong, Qing, Bedke, Jens, Hennenlotter, Jörg, Stenzl, Arnulf, Mischo, Axel, Bihr, Svenja, Schmidinger, Manuela, Vogl, Ursula, Blume, Iris, Karlo, Christoph, Schraml, Peter, Moch, Holger
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2016
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5346651/
https://ncbi.nlm.nih.gov/pubmed/27738339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12618
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados